TRHR
Thyrotropin-releasing hormone receptor
Also known as: TRFR_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P34981
- Gene
- TRHR
- Ensembl
- ENSG00000174417
- Chromosome
- 8
- Canonical length
- 398 aa
- Protein class
- Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters
OverviewNCBI Gene
This gene encodes a G protein-coupled receptor for thyrotropin-releasing hormone (TRH). Upon binding to TRH, this receptor activates the inositol phospholipid-calcium-protein kinase C transduction pathway. Mutations in this gene have been associated with generalized thyrotropin-releasing hormone resistance. [provided by RefSeq, Sep 2011]
Canonical amino-acid sequenceUniProt
398 residues, UniProt reviewed canonical sequence.
>P34981|TRHR
1 MENETVSELN QTQLQPRAVV ALEYQVVTIL LVLIICGLGI VGNIMVVLVV MRTKHMRTPT
61 NCYLVSLAVA DLMVLVAAGL PNITDSIYGS WVYGYVGCLC ITYLQYLGIN ASSCSITAFT
121 IERYIAICHP IKAQFLCTFS RAKKIIIFVW AFTSLYCMLW FFLLDLNIST YKDAIVISCG
181 YKISRNYYSP IYLMDFGVFY VVPMILATVL YGFIARILFL NPIPSDPKEN SKTWKNDSTH
241 QNTNLNVNTS NRCFNSTVSS RKQVTKMLAV VVILFALLWM PYRTLVVVNS FLSSPFQENW
301 FLLFCRICIY LNSAINPVIY NLMSQKFRAA FRKLCNCKQK PTEKPANYSV ALNYSVIKES
361 DHFSTELDDI TVTDTYLSAT KVSFDDTCLA SEVSFSQSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRHR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 0.6 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 0.6 nTPM
- retina: 0.1 nTPM
- thyroid gland: 0.1 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
Single-cell type
- epicardial cells: 41 nCPM
- cardiomyocytes: 22 nCPM
- thyrotrophs: 18 nCPM
- lactotrophs: 14 nCPM
- myonuclei: 5.4 nCPM
- brain excitatory neurons: 4.3 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 13 nTPM
- hippocampal formation: 8 nTPM
- amygdala: 7.4 nTPM
- spinal cord: 4.3 nTPM
- hypothalamus: 3.5 nTPM
- midbrain: 3.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TRHR.
Disease | AllUniProt
Conditions TRHR is implicated in, by any mechanism.
- Hypothyroidism, congenital, non-goitrous, 7 (CHNG7) MIM:618573
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 65 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hypothyroidism, congenital, nongoitrous, 7
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0.27
- gnomAD missense Z
- 0.94
- DepMap mean gene effect
- 0.18
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- G protein-coupled receptor signaling pathway
- phospholipase C-activating G protein-coupled receptor signaling pathway
Molecular functions
- thyrotropin-releasing hormone receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- G protein-coupled receptor, rhodopsin-like
- GPCR, rhodopsin-like, 7TM
- 7 transmembrane receptor (rhodopsin family)
- Thyrotropin-releasing hormone receptor
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRHR as an antibody target. Whether an autoantibody or antibody against TRHR could matter depends on whether native TRHR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRHR is annotated at the cell surface, where native TRHR is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TRHR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...